Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Noll

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Haematologica|April 2, 2026
Therapeutic inhibition of myeloperoxidase with AZD5904 attenuates disease progression in mouse models of early-stage and relapsed multiple myelomaConnor M D Williams, Jacqueline E Noll, Dylan Harnas, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9Jacqueline L Y Chee, Suzan Saidin, David P Lane, et al.
Cancer Letters|February 5, 2020
Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myelomaChee Man Cheong, Krzysztof M Mrozik, Duncan R Hewett, et al.
Scientific Reports|July 30, 2022
Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myelomaAlanah L Bradey, Stephen Fitter, Jvaughn Duggan, et al.
FASEB Bioadvances|July 4, 2020
LCRF-0006, a small molecule mimetic of the N-cadherin antagonist peptide ADH-1, synergistically increases multiple myeloma response to bortezomibKrzysztof M Mrozik, Chee M Cheong, Duncan R Hewett, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001
Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumorsQ R Lu, J K Park, E Noll, et al.
Haematologica|August 13, 2013
Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cellsJacqueline E Noll, Sharon A Williams, Christine M Tong, et al.
Oncogene|July 17, 2012
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155P M Neilsen, J E Noll, S Mattiske, et al.
Cell Reports|March 2, 2022
SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomasNeali Armstrong, Claire M Storey, Sarah E Noll, et al.
JACC. Clinical Electrophysiology|April 20, 2019
Atrial Tachyarrhythmias Among Patients With Left Ventricular Assist Devices: Prevalence, Clinical Outcomes, and Impact of Rhythm Control StrategiesAndrew E Noll, Joseph Adewumi, Ram Amuthan, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Haematologica|April 2, 2026
Therapeutic inhibition of myeloperoxidase with AZD5904 attenuates disease progression in mouse models of early-stage and relapsed multiple myelomaConnor M D Williams, Jacqueline E Noll, Dylan Harnas, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9Jacqueline L Y Chee, Suzan Saidin, David P Lane, et al.
Cancer Letters|February 5, 2020
Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myelomaChee Man Cheong, Krzysztof M Mrozik, Duncan R Hewett, et al.
Scientific Reports|July 30, 2022
Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myelomaAlanah L Bradey, Stephen Fitter, Jvaughn Duggan, et al.
FASEB Bioadvances|July 4, 2020
LCRF-0006, a small molecule mimetic of the N-cadherin antagonist peptide ADH-1, synergistically increases multiple myeloma response to bortezomibKrzysztof M Mrozik, Chee M Cheong, Duncan R Hewett, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2001
Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumorsQ R Lu, J K Park, E Noll, et al.
Haematologica|August 13, 2013
Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cellsJacqueline E Noll, Sharon A Williams, Christine M Tong, et al.
Oncogene|July 17, 2012
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155P M Neilsen, J E Noll, S Mattiske, et al.
Cell Reports|March 2, 2022
SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomasNeali Armstrong, Claire M Storey, Sarah E Noll, et al.
JACC. Clinical Electrophysiology|April 20, 2019
Atrial Tachyarrhythmias Among Patients With Left Ventricular Assist Devices: Prevalence, Clinical Outcomes, and Impact of Rhythm Control StrategiesAndrew E Noll, Joseph Adewumi, Ram Amuthan, et al.
Pageof 13